Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.36 - $11.74 $34,488 - $39,082
3,329 Added 12.08%
30,894 $327,000
Q1 2024

May 14, 2024

BUY
$9.87 - $11.8 $8,438 - $10,089
855 Added 3.2%
27,565 $291,000
Q4 2023

Feb 14, 2024

BUY
$8.38 - $11.58 $91,031 - $125,793
10,863 Added 68.55%
26,710 $300,000
Q3 2023

Nov 14, 2023

BUY
$9.76 - $13.19 $154,666 - $209,021
15,847 New
15,847 $185,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $7.85B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.